Nan Fung Group Holdings LTD Invitae Corp Transaction History

Nan Fung Group Holdings LTD

  • $101 Million
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022
SELL
$2.13 - $9.01 $308,140 - $1.3 Million
-144,667 Reduced 92.73%
11,337 $28,000
Q1 2022

May 13, 2022
SELL
$6.28 - $15.59 $11,668 - $28,966
-1,858 Reduced 1.18%
156,004 $1.24 Million
Q4 2021

Feb 14, 2022
BUY
$14.7 - $28.67 $193,966 - $378,300
13,195 Added 9.12%
157,862 $2.41 Million
Q2 2021

Sep 22, 2021
BUY
$26.09 - $40.4 $3.77 Million - $5.84 Million
144,667 New
144,667 $4.88 Million

Others Institutions Holding NVTA

# of Institutions
56
Shares Held
7.66M
Call Options Held
0
Put Options Held
0
View Full List

About Invitae Corp

NVTA Quotes by TradingView
  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track Nan Fung Group Holdings LTD Portfolio

Follow Nan Fung Group Holdings LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nan Fung Group Holdings LTD, based on Form 13F filings with the SEC.

News

Stay updated on Nan Fung Group Holdings LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email